Evidence map›Paper›PMID 31768034›Full record

ArticleNature chemical biology2020

Global targeting of functional tyrosines using sulfur-triazole exchange chemistry.

Heung Sik Hahm, Emmanuel K Toroitich, Adam L Borne, Jeffrey W Brulet, Adam H Libby, Kun Yuan, Timothy B Ware, Rebecca L McCloud, Anthony M Ciancone, Ku-Lung Hsu

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 223 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Discovery of Covalent Ligands with AlphaFold3.Journal of the American Chemical Society · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Covalent PFKL Activator Suppresses Tumor Growth.bioRxiv : the preprint server for biology · 2025
    Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Heung Sik Hahm *Department of Chemistry, University of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0003-2326-7923
Emmanuel K Toroitich *Department of Chemistry, University of Virginia, Charlottesville, VA, USA.
Adam L Borne *Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0001-5275-4195
Jeffrey W Brulet *Department of Chemistry, University of Virginia, Charlottesville, VA, USA.
Adam H LibbyDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA.
Kun YuanDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA.
Timothy B WareDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0002-2870-7812
Rebecca L McCloudDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA.
Anthony M CianconeDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA.
Ku-Lung HsuDepartment of Chemistry, University of Virginia, Charlottesville, VA, USA. kenhsu@virginia.edu.ORCID http://orcid.org/0000-0001-5620-3972
University of Virginia · USUniversity of Virginia Cancer CenterUniversity of Virginia Health System · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jay William FOX · 1987 to 2026
$72.1M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
Endocannabinoid Biosynthesis in Inflammation and PainR01DA043571 · NIDA · UNIVERSITY OF VIRGINIA · PI Ku-Lung Hsu · 2017 to 2026
$3.5M
NCI NIH HHS P30 CA044579NCI NIH HHS T32 CA009109NIDA NIH HHS R01 DA043571NIGMS NIH HHS T32 GM007055
6 · The paper itself

Abstract

Covalent probes serve as valuable tools for global investigation of protein function and ligand binding capacity. Despite efforts to expand coverage of residues available for chemical proteomics (e.g., cysteine and lysine), a large fraction of the proteome remains inaccessible with current activity-based probes. Here, we introduce sulfur-triazole exchange (SuTEx) chemistry as a tunable platform for developing covalent probes with broad applications for chemical proteomics. We show modifications to the triazole leaving group can furnish sulfonyl probes with ~5-fold enhanced chemoselectivity for tyrosines over other nucleophilic amino acids to investigate more than 10,000 tyrosine sites in lysates and live cells. We discover that tyrosines with enhanced nucleophilicity are enriched in enzymatic, protein-protein interaction and nucleotide recognition domains. We apply SuTEx as a chemical phosphoproteomics strategy to monitor activation of phosphotyrosine sites. Collectively, we describe SuTEx as a biocompatible chemistry for chemical biology investigations of the human proteome.

Indexed as

A549 CellsBinding SitesFluorineGlutathione S-Transferase piHEK293 CellsHumansMolecular ProbesPhosphorylationPhosphotyrosineProtein DomainsProtein Processing, Post-TranslationalProteomicsSulfinic AcidsSulfurTriazolesTyrosineFluorineGlutathione S-Transferase piGSTP1 protein, humanMolecular ProbesPhosphotyrosineSulfinic AcidsSulfurTriazolesTyrosine

Identifiers

PMID31768034
PMCPMC6982592
OpenAlexW2989719215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.